Systematic Financial Management’s Integra LifeSciences IART Stock Holding History

Systematic Financial Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.98M	Sell	1,059,286 -49,313	-4%	-$541K	0.23%	136
2025 Q4	$13.8M	Buy	1,108,599 +48,094	+5%	+$639K	0.32%	121
2025 Q3	$15.2M	Buy	1,060,505 +3,585	+0.3%	+$49.1K	0.37%	107
2025 Q2	$13M	Buy	1,056,920 +120,086	+13%	+$1.74M	0.35%	111
2025 Q1	$20.6M	Buy	936,834 +76,271	+9%	+$1.79M	0.59%	69
2024 Q4	$19.5M	Buy	860,563 +248,817	+41%	+$5.43M	0.5%	89
2024 Q3	$11.1M	Buy	611,746 +214,272	+54%	+$4.97M	0.28%	129
2024 Q2	$11.6M	Buy	397,474 +335,424	+541%	+$9.95M	0.35%	116
2024 Q1	$2.2M	Buy	+62,050	New	+$2.48M	0.06%	179
2020 Q3	–	Sell	-7,075	Closed	-$332K	–	342
2020 Q2	$332K	Buy	+7,075	New	+$348K	0.02%	258

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Systematic Financial Management's IART Position: Q1 2026 in Review

Systematic Financial Management reduced its Integra LifeSciences (IART) stake by 4.4% in Q1 2026, selling an estimated $541K and leaving 1,059,286 shares worth $9.98M. The position accounts for 0.23% of the portfolio, ranked #136.

Systematic Financial Management first reported a position in IART in Q2 2020 and has held it in 10 quarters since. The position peaked at $20.6M in Q1 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Systematic Financial Management held 1,059,286 shares of Integra LifeSciences worth $9.98M as of Q1 2026.
Systematic Financial Management sold 49,313 Integra LifeSciences shares in Q1 2026, an estimated $541K.
Integra LifeSciences made up 0.23% of Systematic Financial Management's portfolio in Q1 2026, its #136 holding.
Systematic Financial Management first reported a position in Integra LifeSciences in Q2 2020 and has held it in 10 quarters since.
Systematic Financial Management's Integra LifeSciences position peaked at $20.6M in Q1 2025.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Systematic Financial Management's 13F filing for Q1 2026, filed 13 May 2026.